US3551437A - Certain 4-(1,2,4-oxadiazole-3 or 5-yl) pyridinium salts and derivatives thereof - Google Patents
Certain 4-(1,2,4-oxadiazole-3 or 5-yl) pyridinium salts and derivatives thereof Download PDFInfo
- Publication number
- US3551437A US3551437A US875527A US87552769A US3551437A US 3551437 A US3551437 A US 3551437A US 875527 A US875527 A US 875527A US 87552769 A US87552769 A US 87552769A US 3551437 A US3551437 A US 3551437A
- Authority
- US
- United States
- Prior art keywords
- oxadiazol
- oxadiazole
- derivatives
- certain
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
- B63H—MARINE PROPULSION OR STEERING
- B63H1/00—Propulsive elements directly acting on water
- B63H1/02—Propulsive elements directly acting on water of rotary type
- B63H1/04—Propulsive elements directly acting on water of rotary type with rotation axis substantially at right angles to propulsive direction
- B63H1/06—Propulsive elements directly acting on water of rotary type with rotation axis substantially at right angles to propulsive direction with adjustable vanes or blades
- B63H1/08—Propulsive elements directly acting on water of rotary type with rotation axis substantially at right angles to propulsive direction with adjustable vanes or blades with cyclic adjustment
Definitions
- This invention relates to new quaternary lower alkoxy- (lower)alkyl-1,2,4-oxadiazolylpyridinium salts which may be illustrated by the following formula:
- R is lower alkyl
- R is lower alkoxy(lower)alkyl
- X is a pharmaceutically acceptable anion
- Z is a trivalent radical selected from the group consisting of and The dotted line represents one double bond, the position of which is dependent upon the definition of Z. When Z is the double bond is between the N and carbon containing R, and when Z has the other meaning, the double bond is in the other position.
- the terms lower alkyl and lower alkoxy include those radicals having 1 to 4 carbon atoms.
- the compounds are crysaalline solids, soluble in water.
- the compounds of the present invention may be prepared by reaction of a 1,2,4-oxadiazolylpyridine with a lower alkoxy(lower)alkyl halide at a temperature of to 200 C. with or without a solvent, such as a lower alkyl alcohol, for a time of one minute to twenty-four hours in an open vessel or a sealed bomb.
- quaternary compounds of the present inven tion are, for example: 1-(2-ethoxyethyl)-4-(5-methyl-1,2, 4-oxadiazol 3 yl)pyridinium chloride, 1-(2-methoxyethyl) -4- (S-methyl-1,2,4-oxadiazol-3 -yl) pyridinium chloride, 1-(2-propoxyethyl) 4 (S-methyl-1,2,4-oxadiazol- 3-yl)pyridinium bromide, 1-(2-ethoxymethyl) 4 (5- methyl-1,2,4-oxadiazol 3 yl)pyridinium iodide, 1-(2- propoxypropyl) 4 (S-methyl-1,2,4-oxadiazol-3-yl)- pyridinium chloride.
- the quaternary compounds of the present invention show hypoglycemic activity which indicates they are use ful as medicaments in the lowering of blood sugar levels.
- the compounds of this invention are administered by gavage as saline solutions to CF1 mice (Carworth Farms, 18-25 grams (4-6 animals). Control animals receive an equivalent volume of saline. Food is withheld from animals after dosing. Blood glucose is determined on 0.05 ml. samples of blood by the method of Hotfman [1. Biol. Chem, 120, 51 (1937)] as adapted to the Technicon AutoAnalyzer and is expressed as percent change from predose values. The data are shown in the table hereinafter. These results show that the compounds of the present invention are useful in lowering the blood glucose concentrations of warm-blooded animals.
- hypoglycemic agents can be incorporated in various pharmaceutical forms such as tablets, capsules, pills and so forth, for immediate or sustained release, by combining with suitable carriers. They may be in the form of dosage units for a single therapeutic dose or in small units for multiple dosages or in larger units for division into single doses. Obviously, in addition to the therapeutic hypoglycemic compounds, there may be present excipients, binders, fillers and other therapeutically inert ingredients necessary in the formulation of the desired pharmaceutical preparation.
- EXAM PLE 1 Preparation of 4-(S-methyl-1,2,4-oxadiazol-3-yl)pyridine 'A mixture of 27 g. of isonicotinamidoxime and 50 ml. of acetic anhydride is warmed on a steam bath for 2 hours, and then heated under reflux for 3 hours. The solvent is distilled and the dark liquid residue is diluted with water. The crystals which form are collected, washed with water, and recrystallized from ethanol to provide colorless crystals, melting point 92-93 C.
- EXAMPLE 2 Preparation of l-(2-ethoxyethyl)-4-(5-methyl-l,2,4-oxadiazol-3-yl)pyridinium chloride A mixture of 5.0 g. of 4-(S-methyl-1,2,4-oxadiazol-3- yl)pyridine and 15 ml. of 2-chloroethyl ethyl ether is heated in a bomb at C. for 20 hours. The excess 2-chloroethyl ether is evaporated and the black residue is recrystallized from isopropyl alcohol-ether to give offwhite crystals, melting point l87188 C.
- EXAMPLE 4 Preparation of l-(3-propoxypropyl)-4-(5-ethyl-1,2,4-oxa diaZol-3-yl)pyridinium chloride A mixture of 5.0 g. of 4-(5-ethyl-l,2,4-oxadiazol-3-yl) pyridine and 15 ml. of 3-chloropropyl propyl ether is heated in a bomb at 130 C. for 20 hours. The excess 3- chloropropyl ether is evaporated and the residue is recrystallized to give the product of the example.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Combustion & Propulsion (AREA)
- Mechanical Engineering (AREA)
- Ocean & Marine Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL6813336A NL6813336A (nl) | 1967-09-22 | 1968-09-18 | Werkwijze voor het bereiden van pyridinederivaten. |
BE721158D BE721158A (de) | 1967-09-22 | 1968-09-20 | |
CH1413168A CH521371A (de) | 1967-09-22 | 1968-09-20 | Verfahren zur Herstellung neuer Cyclopropyl-1,2,4-oxadiazolylpyridine |
DE19681795369 DE1795369A1 (de) | 1967-09-22 | 1968-09-20 | Neue Pyridiniumsalze und Verfahren zu ihrer Herstellung |
FR166957A FR1598975A (fr) | 1967-09-22 | 1968-09-20 | Procédé de préparation de sels de pyridinium. |
FR166958A FR8478M (fr) | 1967-09-22 | 1968-09-20 | Nouveaux dérivés de pyridine et leurs sels de pyridinium, utiles comme relaxants musculaires et antiépileptiques. |
US875525A US3551436A (en) | 1967-09-22 | 1969-11-10 | Certain 4-(thiazolyl) and 4-(oxazolyl) pyridinium salts |
US875527A US3551437A (en) | 1967-09-22 | 1969-11-10 | Certain 4-(1,2,4-oxadiazole-3 or 5-yl) pyridinium salts and derivatives thereof |
US875526A US3555036A (en) | 1967-09-22 | 1969-11-10 | Cyclopropyl-1,2,4-oxadiazolylpyridines |
US127023A US3703577A (en) | 1967-09-22 | 1971-03-22 | 4-(thiazolyl) pyridinium salts and 4-(oxazolyl) pyridinium salts for lowering blood glucose levels |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66970567A | 1967-09-22 | 1967-09-22 | |
US67670667A | 1967-10-20 | 1967-10-20 | |
US69038267A | 1967-12-14 | 1967-12-14 | |
US875525A US3551436A (en) | 1967-09-22 | 1969-11-10 | Certain 4-(thiazolyl) and 4-(oxazolyl) pyridinium salts |
US875527A US3551437A (en) | 1967-09-22 | 1969-11-10 | Certain 4-(1,2,4-oxadiazole-3 or 5-yl) pyridinium salts and derivatives thereof |
US875526A US3555036A (en) | 1967-09-22 | 1969-11-10 | Cyclopropyl-1,2,4-oxadiazolylpyridines |
US127023A US3703577A (en) | 1967-09-22 | 1971-03-22 | 4-(thiazolyl) pyridinium salts and 4-(oxazolyl) pyridinium salts for lowering blood glucose levels |
Publications (1)
Publication Number | Publication Date |
---|---|
US3551437A true US3551437A (en) | 1970-12-29 |
Family
ID=27568835
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US875525A Expired - Lifetime US3551436A (en) | 1967-09-22 | 1969-11-10 | Certain 4-(thiazolyl) and 4-(oxazolyl) pyridinium salts |
US875527A Expired - Lifetime US3551437A (en) | 1967-09-22 | 1969-11-10 | Certain 4-(1,2,4-oxadiazole-3 or 5-yl) pyridinium salts and derivatives thereof |
US875526A Expired - Lifetime US3555036A (en) | 1967-09-22 | 1969-11-10 | Cyclopropyl-1,2,4-oxadiazolylpyridines |
US127023A Expired - Lifetime US3703577A (en) | 1967-09-22 | 1971-03-22 | 4-(thiazolyl) pyridinium salts and 4-(oxazolyl) pyridinium salts for lowering blood glucose levels |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US875525A Expired - Lifetime US3551436A (en) | 1967-09-22 | 1969-11-10 | Certain 4-(thiazolyl) and 4-(oxazolyl) pyridinium salts |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US875526A Expired - Lifetime US3555036A (en) | 1967-09-22 | 1969-11-10 | Cyclopropyl-1,2,4-oxadiazolylpyridines |
US127023A Expired - Lifetime US3703577A (en) | 1967-09-22 | 1971-03-22 | 4-(thiazolyl) pyridinium salts and 4-(oxazolyl) pyridinium salts for lowering blood glucose levels |
Country Status (6)
Country | Link |
---|---|
US (4) | US3551436A (de) |
BE (1) | BE721158A (de) |
CH (1) | CH521371A (de) |
DE (1) | DE1795369A1 (de) |
FR (2) | FR1598975A (de) |
NL (1) | NL6813336A (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571402A (en) * | 1982-06-22 | 1986-02-18 | Schering Corporation | Anti-bronchoconstriction 2-(4'-pyridinyl)-thiazole derivatives, composition, and method of use therefor |
US20080108799A1 (en) * | 2004-09-02 | 2008-05-08 | Andre Weiss | Use Of Thiazolyl-Pyridinium Based Dyes In Optical Layers For Optical Data Recording |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3985754A (en) * | 1975-05-08 | 1976-10-12 | American Cyanamid Company | Para-fluorobenzoylpropyl-N-heterocyclic substituted quaternary salts |
US4528291A (en) * | 1982-06-22 | 1985-07-09 | Schering Corporation | 2-(4'-Pyridinyl)-thiazole compounds and their use in increasing cardiac contractility |
US4488647A (en) * | 1983-07-18 | 1984-12-18 | Paramount Packaging Corporation | Flexible package with easy opening peel seal |
-
1968
- 1968-09-18 NL NL6813336A patent/NL6813336A/xx unknown
- 1968-09-20 DE DE19681795369 patent/DE1795369A1/de active Pending
- 1968-09-20 FR FR166957A patent/FR1598975A/fr not_active Expired
- 1968-09-20 CH CH1413168A patent/CH521371A/de not_active IP Right Cessation
- 1968-09-20 FR FR166958A patent/FR8478M/fr not_active Expired
- 1968-09-20 BE BE721158D patent/BE721158A/xx unknown
-
1969
- 1969-11-10 US US875525A patent/US3551436A/en not_active Expired - Lifetime
- 1969-11-10 US US875527A patent/US3551437A/en not_active Expired - Lifetime
- 1969-11-10 US US875526A patent/US3555036A/en not_active Expired - Lifetime
-
1971
- 1971-03-22 US US127023A patent/US3703577A/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571402A (en) * | 1982-06-22 | 1986-02-18 | Schering Corporation | Anti-bronchoconstriction 2-(4'-pyridinyl)-thiazole derivatives, composition, and method of use therefor |
US20080108799A1 (en) * | 2004-09-02 | 2008-05-08 | Andre Weiss | Use Of Thiazolyl-Pyridinium Based Dyes In Optical Layers For Optical Data Recording |
US7655767B2 (en) | 2004-09-02 | 2010-02-02 | Clariant Finance (Bvi) Limited | Use of thiazolyl-pyridinium based dyes in optical layers for optical data recording |
Also Published As
Publication number | Publication date |
---|---|
FR1598975A (fr) | 1970-07-15 |
CH521371A (de) | 1972-04-15 |
FR8478M (fr) | 1972-06-09 |
BE721158A (de) | 1969-03-20 |
US3551436A (en) | 1970-12-29 |
DE1795369A1 (de) | 1972-01-05 |
US3555036A (en) | 1971-01-12 |
US3703577A (en) | 1972-11-21 |
NL6813336A (nl) | 1969-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2961377A (en) | Oral anti-diabetic compositions and methods | |
CN101596191B (zh) | 用作代谢调节剂的丙二酰基辅酶a脱羧酶抑制剂 | |
US3551437A (en) | Certain 4-(1,2,4-oxadiazole-3 or 5-yl) pyridinium salts and derivatives thereof | |
BRPI0615046A2 (pt) | uso de um composto, e, formulação para administração oral | |
US2823164A (en) | Method of preparing 3, 5, 3' l-tri-iodothyronine and pharmaceutical compositions thereof | |
JP2001335476A (ja) | 三環化合物の新規用途 | |
US3125488A (en) | Method of inducing analgesia by | |
JPH049331A (ja) | 肝機能改善剤 | |
US4056626A (en) | Pharmaceutical composition containing benzofuran derivative | |
IL43079A (en) | 2-amino-1,4-dihydropyridines,their production and pharmaceutical compositions containing them | |
EP0074411B1 (de) | Ascorbinsäureabkömmlinge | |
US3143469A (en) | Anti-cholesterol nicotinic acid nu-oxide | |
US3511848A (en) | Certain 4-(isoxazol-3 or 5-yl)-pyridinium salts | |
US2954381A (en) | Heteroaryloxazolidinediones | |
US3332846A (en) | Method of inducing hypoglycemia with a substituted indole | |
US4376119A (en) | Benzothiazine derivative | |
US3255190A (en) | Amine salts of pyrrolidone carboxylic acid | |
US3341413A (en) | Compositions containing pyrazolylpyridinium salts and method of administration | |
WO1991012803A1 (en) | Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents | |
JPS6275A (ja) | 肝疾患治療剤 | |
US3466373A (en) | Analgesic and anti-inflammatory composition consisting essentially of 2-(2,3-xylylamino)-nicotinic acid | |
US3232939A (en) | Pyridylethyl-barbituric acids | |
US3098868A (en) | Amine salts of glycuronic acid | |
US2847474A (en) | 2-(4-bromophenyl)-1, 3-diketohydrindene | |
JPS5833841B2 (ja) | 動脈硬化症用および血糖降下用医薬組成物 |